Food and Drug Regulations, C.R.C., c. 870

Section C.01.027

Cite as Food and Drug Regulations, C.R.C., c. 870, s. C.01.027 · current to June 17, 2026 · regulation last amended June 17, 2026

Statute Watch

Get an alert when a bill in Parliament would change this section, and every time it moves.

The text

(1) Where a person advertises to the general public a drug for human use, the person shall not make any representation other than with respect to the brand name, proper name, common name, price and quantity of the drug if it (a) contains a drug set out in the table to section C.01.021; and (b) carries on its label (i) a statement of the recommended single or daily adult dosage that results in a single or daily adult dosage of the drug referred to in paragraph (a) in excess of the maximum dosage set out in the table to section C.01.021 for that drug, or (ii) a statement that shows a concentration of the drug referred to in paragraph (a) in excess of the maximum limit set out in the table to section C.01.021 for that drug. (2) Subsection (1) does not apply to products containing (a) acetaminophen; (b) acetylsalicylic acid; (c) choline salicylate; (d) magnesium salicylate; or (e) sodium salicylate. (3) [Repealed, SOR/94-409, s. 1] (4) Where a person advertises to the general public a drug for human use that contains acetylsalicylic acid, the person shall not make any representation with respect to its administration to or use by children or teenagers.
Read the Food and Drug Regulations on the Justice Laws Website ↗

Made under Food and Drugs Act, R.S.C. 1985, c. F-27.

Bills in Parliament that would change this section 0

No bill we hold would amend or repeal this section.